Dr. Joseph McQuail, an associate professor with the Floyd School of Medicine's Pharmacology, Physiology and Neuroscience department, has received a new two-year R03 award from the National Institute on Aging of the National Institutes of Health for “Modulation of Brain D-Serine Metabolism and Signaling in Aging and Alzheimer’s Disease.” The award supports new research in the McQuail Lab at the University of South Carolina School of Medicine on brain mechanisms of memory in aging and Alzheimer’s disease.
D-serine helps regulate NMDA receptors, communication points between brain cells that are essential for learning and memory. These receptors must be carefully regulated: too little activity can interfere with memory, while excessive activity can contribute to injury of brain cells. The study will examine how aging and Alzheimer’s disease may disrupt this balance in different ways.
The research focuses on two enzymes that regulate D-serine: serine racemase, which produces it, and D-amino acid oxidase (DAO), which degrades it. Using a rat model that develops Alzheimer’s-like pathology, the team will use targeted genetic approaches to alter these pathways in the hippocampus, a brain region essential for memory, and measure effects on memory, brain-cell communication, and neurodegeneration. They will also examine DAO in human brain, spinal-fluid, and blood samples from people with Alzheimer’s disease.
Preliminary findings from the McQuail Lab helped motivate the project. In aged rats, blocking DAO improved spatial memory and restored molecular evidence of NMDA receptor signaling associated with cognitive activity. Analyses of human data also found that DAO gene expression in the hippocampus increases with age and with Alzheimer’s disease severity. The new studies will determine whether these changes are protective, harmful, or dependent on the stage of aging and disease.